Nordic Bone
ABOUT USINVESTORSPIPELINENEWSCAREERSCONTACT

John Barberich

Chairman
 

Jeremy Curnock Cook

Executive Chairman, Bioscience Managers Limited
 

Klaus Eldrup-Jorgensen, M.D.

Founder and CEO, ISG A/S
 

Bobby W. Sandage, Jr., Ph.D.

Former Executive Vice President, Research and Development and Chief Scientific Officer, Indevus Pharmaceuticals, Inc.
 

Philip J. Young

President and CEO, Osteologix, Inc.
 

 

 

JOHN BARBERICH

Chairman

John M. Barberich was appointed a director and Chairman of the Board of Directors of the Company on December 2X, 2009. Mr. Barberich has been a consultant to biotech related companies since 2003 and since September 2005 has been a Financial Advisor to Nordic Biotech Advisors ApS, a firm which provides investment advisory services to Nordic Biotech K/S and Nordic Biotech Opportunity Fund, security holders in the Company. Prior to 2003, Mr. Barberich served as Vice President and Chief Financial Officer of three biopharmaceutical companies: Omrix Biopharmaceuticals (now part of Johnson & Johnson), Scriptgen Pharmaceuticals (now known as Anadys Pharmaceuticals) (NASDAQ: ANDS) and ACADIA Pharmaceuticals (NASDAQ: ACAD). Previously, Mr. Barberich was a Certified Public Accountant and served in tax management positions with Price Waterhouse and The Henley Group, Inc. Mr. Barberich also currently serves on the Board of Directors of several privately-held biotech related companies.

He received his B.S. in Finance, with highest distinction, from The Pennsylvania State University and his M.P.A. from Georgia State University.